De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease

Published:2023-04-23 Issue: Volume: Page:
ISSN:
Container-title:The 2nd International Electronic Conference on Biomedicines
language:
Short-container-title:

Author:

Lopez Edgar Clyde R.¹²^ORCID

Affiliation:

1. Chemical Engineering Department, Adamson University, 900 San Marcelino St., Ermita, Manila 1000, Philippines

2. Nanotechnology Research Laboratory, Department of Chemical Engineering, University of the Philippines Diliman, Quezon City 1101, Philippines

Publisher

MDPI

Link

https://www.mdpi.com/2673-9992/21/1/37/pdf

Reference35 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2;Gorbalenya;Nat. Microbiol.,2020

2. Therapeutic strategies of COVID-19: From natural compounds to vaccine trials;Bouyahya;Biointerface Res. Appl. Chem.,2021

3. The broad-spectrum antiviral recommendations for drug discovery against COVID-19;Hazafa;Drug Metab. Rev.,2020

4. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action;Yousefi;Biochem. Pharmacol.,2021

5. WHO Solidarity Trial Consortium (2021). Repurposed Antiviral Drugs for COVID-19—Interim WHO Solidarity Trial Results. N. Engl. J. Med., 384, 497–511.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP